PV Bulletin
PvBulletin
Home /Regulators/Dexcom G7 Sensor Lot Recall – Unauthorized Distribution of Non-Conforming Lots in Canada
RegulatorsHealth CanadaCanada

Dexcom G7 Sensor Lot Recall – Unauthorized Distribution of Non-Conforming Lots in Canada

Two lots of Dexcom G7 Sensor (1-Pack) distributed in Canada by an unauthorized third party despite being intended for destruction due to non-conformance.

PV Impact Brief

Urgency: HighConfidence: high
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Action needed

Identify and quarantine products from lots 1725204004 and 1725069002; contact patients who received sensors from these lots; report adverse events if any.

Owner

Regulatory Intelligence Lead

Review cadence

as needed

Regulatory action details

Action type
Health product recall
Publication date
2026-06-03
Safety issue
Unauthorized third-party distribution of 2 Dexcom G7 sensor lots in Canada that were intended for destruction as they did not meet Dexcom product standards.

Affected products

  • Dexcom G7 Sensor 1 Pack
    Dexcom, Inc.
    17252040041725069002

PV internal implications

Contact the manufacturer if you require additional information.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 3, 2026

Full briefing

What changed

Health Canada published a recall alert for two unauthorized lots of Dexcom G7 Sensor distributed in Canada.

Why it matters

Patients using sensors from these lots may experience inaccurate glucose readings, leading to potential harm from incorrect insulin dosing.

Practical implication

Identify and quarantine products from lots 1725204004 and 1725069002; contact patients who received sensors from these lots; report adverse events if any.

#Safety Signals#Health product recall#Health Canada#safety_signal#firecrawl-agent#regulatory-extraction

Related updates for your role

RegulatorsTherapeutic Goods Administration (TGA)Australia

Nature's Own Glucosamine Sulfate with Chondroitin and Nature's Own Magnesium Glycinate 1150mg Recall by Sanofi Consumer Healthcare

Regulatory action
Recall
Nature’s Own Glucosamine Sulfate with Chondroitin (320 pack) · Sanofi Consumer Healthcare
Lot/batch: 1662937
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Return recalled products to place of purchase for refund or contact Customer Care for return arrangements.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
RegulatorsMedicines and Healthcare products Regulatory Agency (MHRA)United Kingdom

MHRA Class 2 Recall: ChloraPrep 2% applicators (potential sterility breach)

Regulatory action
Class 2 Medicines Recall
ChloraPrep 2% 1mL applicator · Becton Dickinson UK Ltd
Lot/batch: All lots with an expiry date up to and including 02/2028. For a full list, see Annex 1.
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Identify and quarantine all impacted batches of ChloraPrep 2% 1mL and Frepp 2% 1.5mL applicators; return to Becton Dickinson UK Ltd.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
RegulatorsHealth CanadaCanada

Omnipod Insulin Management System Recall in Canada

Regulatory action
Health product recall
Omnipod Insulin Management System · Insulet Corporation
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Identify affected lots and implement recall procedures as per Health Canada guidelines.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
RegulatorsMedicines and Healthcare products Regulatory Agency (MHRA)United Kingdom

MHRA Largest Seizure of Unlicensed Weight Loss Medicines

Regulatory action
Enforcement Action / Public Safety Alert
Unlicensed weight loss medicines · Illicit manufacturing operation (unnamed)
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed

Review adverse event reports for potential links to counterfeit weight loss medicines; check product supply chain for unlicensed sources.

Process impact
Signal ManagementLabeling
SOP impact

2 SOPs may need review

Urgency: HighConfidence: high
Read impact brief →
Dexcom G7 Sensor Lot Recall – Unauthorized Distribution of Non-Conforming Lots in Canada | PV Bulletin